Share your requirements to help us to customize the report.
   I acknowledge that I have read the Privacy Policy
Confidentiality

We respect your privacy rights and safeguard your personal information. We prevent the disclosure of personal information to third parties.

Our Clients

  • Schineder Electric
  • KSIA - Korea Semiconductor Industry Association
  • Hitachi Astemo Limited
  • Samsung Electronics
  • Halvo holdings
  • NTT corporation
  • AGC Inc
  • Siemens AG
  • Unilever
  • Merck Pharmaceuticals
  • Atlas Copco
  • Hologic - Medical Technology company
  • Novartis
  • Henkel
  • Reckitt
  • Schineder Electric
  • KSIA - Korea Semiconductor Industry Association
  • Hitachi Astemo Limited
  • Samsung Electronics
  • Halvo holdings
  • NTT corporation
  • AGC Inc
  • Siemens AG
  • Unilever
  • Merck Pharmaceuticals
  • Atlas Copco
  • Hologic - Medical Technology company
  • Novartis
  • Henkel
  • Reckitt
  • FAQs

    Automated Cell Imaging System Market size was valued at USD 137.93 Billion in 2024 and is poised to grow from USD 149.24 Billion in 2025 to USD 280.35 Billion by 2033, growing at a CAGR of 8.2% during the forecast period (2026–2033).

    The market is controlled by a few manufacturers. The product requires a huge amount of capital to be invested for setting up and also on research & development. Due to low competition the prices have been high. Major manufacturers include- General Electric Company, Olympus Corporation, PerkinElmer Inc., Sartorius AG, and Thermo Fisher Scientific. These major manufacturers having advanced proprietary products are getting an edge over the other market players. 'General Electric Company (USA)', 'Olympus Corporation (Japan) ', 'PerkinElmer Inc. (USA) ', 'Sartorius AG (Germany) ', 'Thermo Fisher Scientific Inc. (USA) ', 'West Medica (Austria) ', 'Norma Diagnostika GmbH (Germany) ', 'BioView Ltd. (Israel) ', 'Caliber I.D. (USA) ', 'Molecular Devices, LLC (USA) ', 'Nikon Corporation (Japan) ', 'Leica Microsystems GmbH (Germany) ', 'Carl Zeiss AG (Germany) ', 'Agilent Technologies, Inc. (USA) ', 'Becton, Dickinson and Company (USA) ', 'Merck KGaA (Germany) ', 'Tecan Group Ltd. (Switzerland) ', 'Danaher Corporation (USA)'

    Due to changes in lifestyle and radiation our body shows some deformities in genes. This creates irregular division of cell leading to Tumors. The exposure of certain chemicals to water, food, and soil also causes cancer. Development of new types of cancer also requires automated cell imaging systems to identify the dynamics and functions of telomeric repeat-containing RNA. Automated cell imaging is becoming popular and unique tool for cellular research by looking at digital microscopic images of cancerous cell.

    Increased in Research and Development of New Drugs: Major pharmaceutical companies are investing on new technologies highly to find new vaccine and drugs. Automated cell imaging systems help the researchers by minimizing the human error and time needed for human intervention in experiments having long durations, large chemical libraries, or both. The system acquires and analyzes high resolution images.

    North America holds the largest market share across the world. It is due to technological advancement in the healthcare industry. The USA has one of the highest and advanced diagnostic laboratories across the globe. The main driver in the region is an extensive patient base. Due to high consumption of alcohol and obesity the number of cancer patients are increasing. According to a report, the USA has projected 6,09,360 cancer deaths in 2022.

    Feedback From Our Clients

    Global Automated Cell Imaging System Market

    Report ID: SQMIG35J2035

    $5,300
    BUY NOW GET FREE SAMPLE